reduced death rate

Remdesivir linked to reduced death risk in severe COVID-19 patients

New York: New data revealed by Gilead Sciences has shown that its antiviral drug remdesivir reduces death risk of severe Covid-19 patients by as much as 62 per cent when compared with standard…